tetano
Editor, Senior Moderator
Respir Med Case Rep. 2020 May 12:101087. doi: 10.1016/j.rmcr.2020.101087. [Epub ahead of print]
The potential role of TNFα in 2019 novel coronavirus pneumonia.
Ye W[SUP]1[/SUP], Lu S[SUP]2[/SUP], Xue A[SUP]3[/SUP].
Author information
Abstract
The outbreak of 2019 novel coronavirus has spread rapidly in multiple countries. We report the first case of 2019-nCoV infection in a patient with Ankylosing Spondylitisthe (AS), who was a biological agent (anti-TNFα) user in Wenzhou, China, and describe the clinical course and management of the case.
? 2020 The Authors. Published by Elsevier Ltd.
KEYWORDS:
2019 novel coronavirus; Rheumatic disease; Tumor necrosis factor-α
PMID:32399393PMCID:PMC7215148DOI:10.1016/j.rmcr.2020.101087
Free PMC Article
The potential role of TNFα in 2019 novel coronavirus pneumonia.
Ye W[SUP]1[/SUP], Lu S[SUP]2[/SUP], Xue A[SUP]3[/SUP].
Author information
Abstract
The outbreak of 2019 novel coronavirus has spread rapidly in multiple countries. We report the first case of 2019-nCoV infection in a patient with Ankylosing Spondylitisthe (AS), who was a biological agent (anti-TNFα) user in Wenzhou, China, and describe the clinical course and management of the case.
? 2020 The Authors. Published by Elsevier Ltd.
KEYWORDS:
2019 novel coronavirus; Rheumatic disease; Tumor necrosis factor-α
PMID:32399393PMCID:PMC7215148DOI:10.1016/j.rmcr.2020.101087
Free PMC Article